X-100408005-C-G
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The ENST00000373034.8(PCDH19):c.593G>C(p.Arg198Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R198L) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000373034.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDH19 | NM_001184880.2 | c.593G>C | p.Arg198Pro | missense_variant | 1/6 | ENST00000373034.8 | NP_001171809.1 | |
PCDH19 | NM_001105243.2 | c.593G>C | p.Arg198Pro | missense_variant | 1/5 | NP_001098713.1 | ||
PCDH19 | NM_020766.3 | c.593G>C | p.Arg198Pro | missense_variant | 1/5 | NP_065817.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDH19 | ENST00000373034.8 | c.593G>C | p.Arg198Pro | missense_variant | 1/6 | 1 | NM_001184880.2 | ENSP00000362125 | A1 | |
PCDH19 | ENST00000255531.8 | c.593G>C | p.Arg198Pro | missense_variant | 1/5 | 1 | ENSP00000255531 | P5 | ||
PCDH19 | ENST00000420881.6 | c.593G>C | p.Arg198Pro | missense_variant | 1/5 | 1 | ENSP00000400327 | A1 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 25
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 25, 2016 | The p.R198P variant (also known as c.593G>C), located in coding exon 1 of the PCDH19 gene, results from a G to C substitution at nucleotide position 593. The arginine at codon 198 is replaced by proline, an amino acid with dissimilar properties. This variant has been determined to be the result of a de novo mutation in one family with an isolated case of developmental delay and seizures. A different alteration located at the same position, p.R198L (also known as c.593G>T), was detected in a female individual with afebrile, focal, tonic, and tonic-clonic seizures (Higurashi N et al. Epilepsy Res., 2013 Sep;106:191-9). Based on our internal structural analysis, this arginine directly interacts with three adjacent amino acids, two of which coordinate Ca2+ binding, and this variant is anticipated to result in a decrease in structural stability. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at